Leadtek Research Inc. (TPE:2465)
Taiwan · Delayed Price · Currency is TWD 54.20
-1.40 (-2.52%)
Mar 26, 2026, 1:30 PM CST
Leadtek Research Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 4,436 | 4,296 | 4,276 | 5,311 | 8,823 |
| 4,436 | 4,296 | 4,276 | 5,311 | 8,823 | |
Revenue Growth (YoY) | 3.26% | 0.46% | -19.49% | -39.80% | 93.99% |
Cost of Revenue | 4,000 | 3,928 | 3,648 | 4,705 | 7,253 |
Gross Profit | 435.6 | 368.03 | 628.28 | 606.81 | 1,570 |
Selling, General & Admin | 254.46 | 545.71 | 529.35 | 563.66 | 809.85 |
Research & Development | 62.09 | 221.44 | 203.81 | 188.63 | 205.62 |
Operating Expenses | 349.08 | 779.12 | 726.8 | 752.29 | 1,015 |
Operating Income | 86.52 | -411.09 | -98.52 | -145.48 | 554.62 |
Interest Expense | -19.38 | -28.14 | -36.16 | -25.44 | -14.86 |
Interest & Investment Income | 4.36 | 11.16 | 4.13 | 2.11 | 2.34 |
Earnings From Equity Investments | -21.76 | 0.01 | 0.12 | 0.11 | 0.13 |
Currency Exchange Gain (Loss) | 19.59 | -0.27 | -13.17 | -53.38 | -5.13 |
Other Non Operating Income (Expenses) | 3.23 | -4.91 | 10.77 | 28.07 | 8.57 |
EBT Excluding Unusual Items | 72.55 | -433.23 | -132.83 | -194.02 | 545.67 |
Gain (Loss) on Sale of Investments | - | - | 0.03 | -0.62 | 0.08 |
Asset Writedown | - | - | - | - | 0.51 |
Other Unusual Items | - | - | - | -6.78 | -0.7 |
Pretax Income | 72.55 | -433.23 | -132.8 | -201.42 | 545.56 |
Income Tax Expense | 24.96 | 6.68 | 27.19 | -5.72 | 110.93 |
Earnings From Continuing Operations | 47.59 | -439.91 | -159.99 | -195.71 | 434.63 |
Earnings From Discontinued Operations | -11.04 | - | - | - | - |
Net Income to Company | 36.55 | -439.91 | -159.99 | -195.71 | 434.63 |
Minority Interest in Earnings | -0.09 | -1.3 | 0.26 | -0.11 | 0.63 |
Net Income | 36.45 | -441.21 | -159.73 | -195.81 | 435.26 |
Net Income to Common | 36.45 | -441.21 | -159.73 | -195.81 | 435.26 |
Net Income Growth | - | - | - | - | 1525.61% |
Shares Outstanding (Basic) | 85 | 84 | 63 | 59 | 59 |
Shares Outstanding (Diluted) | 85 | 84 | 63 | 59 | 59 |
Shares Change (YoY) | 0.99% | 33.01% | 7.07% | -0.15% | 0.15% |
EPS (Basic) | 0.43 | -5.26 | -2.53 | -3.32 | 7.38 |
EPS (Diluted) | 0.43 | -5.26 | -2.53 | -3.32 | 7.37 |
EPS Growth | - | - | - | - | 1522.52% |
Free Cash Flow | 23.95 | -63.37 | -79.49 | -379.02 | 108.24 |
Free Cash Flow Per Share | 0.28 | -0.76 | -1.26 | -6.43 | 1.83 |
Dividend Per Share | - | - | - | - | 0.909 |
Gross Margin | 9.82% | 8.57% | 14.69% | 11.43% | 17.79% |
Operating Margin | 1.95% | -9.57% | -2.30% | -2.74% | 6.29% |
Profit Margin | 0.82% | -10.27% | -3.74% | -3.69% | 4.93% |
Free Cash Flow Margin | 0.54% | -1.47% | -1.86% | -7.14% | 1.23% |
EBITDA | 137.47 | -387.41 | -79.37 | -127.21 | 570.83 |
EBITDA Margin | 3.10% | -9.02% | -1.86% | -2.40% | 6.47% |
D&A For EBITDA | 50.96 | 23.67 | 19.15 | 18.27 | 16.22 |
EBIT | 86.52 | -411.09 | -98.52 | -145.48 | 554.62 |
EBIT Margin | 1.95% | -9.57% | -2.30% | -2.74% | 6.29% |
Effective Tax Rate | 34.40% | - | - | - | 20.33% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.